Tiagabine
Tiagabine Hydrochloride is a generic anti-epileptic medication used to help control seizures by reducing abnormal electrical activity in the brain. Available as oral tablets in strengths of 2mg, 4mg, 12mg, and 16mg, it was manufactured by Amneal Pharmaceuticals NY LLC and is now discontinued. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Tiagabine Hydrochloride is a generic anti-epileptic medication used to help control seizures by reducing abnormal electrical activity in the brain. Available as oral tablets in strengths of 2mg, 4mg, 12mg, and 16mg, it was manufactured by Amneal Pharmaceuticals NY LLC and is now discontinued. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Tiagabine",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Tiagabine — ANDA 020646 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020646"
}
]
|
| identifier | ANDA020646 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-manufacturers",
"drug-safety",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Tiagabine |
